Elinzanetant is an oral, centrally acting dual neurokinin‑1 and neurokinin‑3 receptor antagonist that modulates the hypothalamic thermoregulatory pathway.It reduces vasomotor symptoms without hormonal activity.
Approved Indications
Moderate to severe vasomotor symptoms (hot flashes, night sweats) associated with menopause
Key Features
Dual NK₁/NK₃ inhibition
Non‑hormonal, oral, once‑daily
Effective for moderate‑severe hot flashes
Favorable safety and tolerability profile
Applications
API, intermediates, reference standards for R&D, generic registration and commercial manufacturing.
ECROBOT CO., Ltd, Business Registration Number : 220-88-71747, CEO J.W.Park, TEL : +82-2-552-7676, E-mail : E-mail : Contact us Address : (Hwanghwa B/D 11F, Yeoksam-dong)320, Gangnam-daero, Gangnam-gu, Seoul, South Korea
China [CN] 
Click enlarge Image